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derivativesAbstract In this paper, we have described the conventional and microwave methods for the syn-
thesis of 1-[2-(2-chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)(1,3,4-oxadiazolin-3-yl)]-3-(aryl)-
prop-2-en-1-ones (4a–l). Through this method, we have observed a decrease in reaction time and
a better yield than the previously described conventional method. The application of microwave
irradiation (MWI) is used for carrying out chemical transformations which were pollution free
and eco-friendly. The structures of the compounds were characterized by IR, NMR and mass spec-
tral data. These compounds (4a–l) were evaluated for their in vitro antimicrobial screening on dif-
ferent strains of bacteria and fungi. Among the compounds tested, compound 4h showed the
highest activity.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The quinoline nucleus is an important class of heterocyclic
compounds found in many synthetic and natural products witha wide range of pharmacological activities, such as antimalarial
(Larsen et al., 1996), anti-inﬂammatory (Chen et al., 2001),
antiasthmatic (Roma et al., 2000), antibacterial (Dube et al.,
1998) and tyrosine kinase inhibiting agents (Billker et al.,
1998). The quinoline ring systems are important structural units
in naturally occurring alkaloids and synthetic analogues with
interesting biological activities. Therefore, the development of
new and efﬁcient synthetic route for the preparation of their
analogues is an important aspect both in synthetic chemistry
and medicinal chemistry (Balasubramanian and Keay, 1996;
Ranu et al., 2003; Wada et al., 2003; Kobayashi et al., 2003).
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able attention from synthetic organic chemists due to their di-
verse biological activities (Omar et al., 1996; Hui et al., 2002;
Mohan et al., 2004). Several research groups have contributed
for the development of methods for the synthesis of 1,3,4-oxa-
diazoles (Chiba and Mitsuhiro, 1992; Bacu et al., 2003; Bhat
et al., 2004). However, these procedures are time consuming
and proceed in low yields. Therefore, a convenient and eco-
friendly method for the synthesis of 1,3,4-oxadiazoles is highly
desirable.
Chalcones are natural biocides (Geiger and Conn, 1945)
and are well known intermediates for synthesizing various het-
erocycles. Chalcones and their derivatives are also medicinally
important. Many chalcone derivatives have been reported to
possess antimalarial, antibacterial and antifungal properties
(Katritzky, 1984). Anticancer properties of some simple chal-
cone derivatives have also been reported in literature (Rezig
et al., 2000; Ducki et al., 1996). The synthesis of quinolinyl
chalcones is scarcely reported in literature. Sayed et al.
(1976) and Ibrahim et al. (1996) have synthesized a few quin-
oline–chalcone derivatives by Claisen–Schmidt condensation
reaction. Dominguez et al. (2001) have reported the synthesis
of some quinoline–chalcones and claimed their antimalarial
activity. Moussaoui et al. (2002) have also described the syn-
thesis of quinolinyl chalcones and claimed their cytotoxicity
in K 562 human leukaemia cell lines.
The formation of heterocyclic rings by cyclocondensation
reactions is typically a process well-suited for the microwave
technology. Many of these condensation reactions require high
temperatures and conventional reaction conditions very often
involve heating the reactants in an oil, metal or sand bath
for many hours or even days. An example is the formation
of 4-hydroxy-1-H-quinoline-2-ones from anilines and malonic
esters. The corresponding conventional, thermal protocol in-
volves heating the two components in equimolar amounts in
an oil bath at 220–300 C for several hours (without solvent),
whereas similar high yields can be obtained by microwave
heating at 250 C for 10 min (Kappe, 2004). This promptedScheme 1 Synthesis of 1-[2-(2-chloro-6-methyl(3-quinolyl))-5-(4-nitrus to adopt the MWI method for the synthesis of bio-active
heterocyclic molecules.
The present study aims at preparing quinoline–oxadiazole–
chalcone derivatives. The solvent-free organic reactions
assisted by microwave irradiation in organic synthesis can
increase the purity of the resulting products, enhance the
chemical yield and shorten the reaction time. Solvent-free reac-
tion leads to a clean, eco-friendly and economic technology.
Reaction on solid support without using solvent usually with
a closed vessel in Synthos-3000, Anton Paar microwave reac-
tion system are currently popular among synthetic chemists
to create eco-friendly atmosphere (Loupy, 2002; Varma
et al., 1998; Rana et al., 2009).
Looking at the medicinal importance of quinolines, 1,3,4-
oxadiazoles and chalcones, we have designed and synthesized
a series of 1-[2-(2-chloro-6-methyl(3-quinolyl))-5-(4-nitro-
phenyl)(1,3,4-oxadiazolin-3-yl)]-3-(aryl)prop-2-en-1-ones (4a–
l) (Scheme 1) by conventional and microwave methods. The
physical constants by conventional method are shown in Ta-
ble 1 and by microwave method are shown in Table 2. The
structures of the compounds synthesized were assigned on
the basis of IR, 1H NMR, 13C NMR and mass spectral data.
In the ﬁrst step, acetic anhydride cleaves to give acetyl car-
bocation and acetate carbanion, which will be used in the reac-
tion with aroylhydrazone intermediate. The lone pair present
over nitrogen atom will attack on the cationic carbon of 2-
chloro-6-methylquinoline-3-carbaldehyde moiety, which will
undergo self-condensation reaction to form aroylhydrazone
derivative. Due to the keto-imine tautomerization, the keto
group of aroylhydrazone derivative converts to hydroxyl
group. The negatively charged oxygen atom which is formed
due to deprotonation of the hydroxyl group will attack on
C‚N bond to form oxadiazole ring. The nitrogen anion will
attack on acetyl carbocation to form acetyl derivative of oxa-
diazole moiety. Here acetyl group undergoes Claisen–Schmidt
condensation reaction which is a well known reaction. The
reaction mechanism is described in Scheme 2 by taking the
example of compound 4a–l.ophenyl)(1,3,4-oxadiazolin-3-yl)]-3-(aryl)prop-2-en-1-ones (4a–l).
Table 1 The compounds (4a–l) synthesized by the conventional method.
Compd. No. -R M.F. Yield (%) m.p. (C) Reaction time (h) Analysis (%)
C H N
4a -2-C1 C27H18Cl2N4O4 76 278 6 60.80 60.85 3.40 3.47 10.50 10.55
4b -3-C1 C27H18Cl2N4O4 64 243 5 60.80 60.84 3.40 3.46 10.50 10.56
4c -4-C1 C27H18Cl2N4O4 73 223 7.5 60.80 60.86 3.40 3.46 10.50 10.55
4d -2-NO2 C27H18ClN5O6 68 247 7 59.62 59.67 3.33 3.39 12.87 12.93
4e -3-NO2 C27H18ClN5O6 62 231 6.5 59.62 59.68 3.33 3.37 12.87 12.93
4f -4-NO2 C27H18ClN5O6 69 239 5.5 59.62 59.67 3.33 3.38 12.87 12.94
4g -2-OH C27H19ClN4O5 67 200 6 62.98 62.99 3.71 3.77 10.88 10.93
4h -3-OH C27H19ClN4O5 65 249 7 62.98 62.96 3.71 3.76 10.88 10.92
4i -4-OH C27H19ClN4O5 58 236 6.8 62.98 62.97 3.71 3.77 10.88 10.94
4j -4-CH3 C28H21ClN4O4 73 220 6.5 65.56 65.62 4.12 4.18 10.92 10.97
4k -4-OCH3 C28H21ClN4O5 73 198 8 63.58 63.64 4.00 4.06 10.59 10.65
4l 3,4,5-(OCH3)3 C30H25ClN4O7 64 221 7.5 61.17 61.22 4.27 4.32 9.51 9.56
Table 2 The compounds (4a–l) synthesized by the microwave
method.
Compd.
No.
-R Reaction
time (min)
Yield
(%)
m.p.
(C)
4a -2-C1 1.7 77 278–280
4b -3-C1 2.5 68 243–244
4c -4-C1 1.5 78 223–225
4d -2-NO2 3.5 71 247–249
4e -3-NO2 4.2 65 231–233
4f -4-NO2 3 72 239–240
4g -2-OH 2.5 70 200–202
4h -3-OH 3.5 74 249–250
4i -4-OH 2 63 236–238
4j -4-CH3 4 76 220–221
4k -4-OCH3 2.5 77 198–200
4l 3,4,5-(OCH3)3 3 69 221–223
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2.1. Materials and methods
All the required chemicals were purchased from E. Merck. 2-
Chloro-6-methylquinoline-3-carbaldehyde was synthesized by
Meth-Cohn and Narine (1978) and modiﬁed (Kappe et al.,
1994; Bawa and Kumar, 2009). IR spectra were recorded on
a Perkin Elmer FT-IR spectrophotometer. 1H NMR and 13C
NMR spectra were recorded on a Bruker DPX-40C instrument
at 400 MHz. Chemical shifts are reported in ppm referenced to
the residual solvent signal. Mass spectra were recorded on
JEOL SX-102. Elemental analysis was performed by a Per-
kin-Elmer 2400-CHN analyzer. Melting points were recorded
on a Gallenkemp apparatus and were uncorrected. Aluminium
coated TLC plates 60 F245 (E. Merck) were used for monitoring
the reaction and purity of compounds. In the conventional
method, compounds were synthesized by using a Random syn-
thesizer. Bookie Rotavapour was used for the distillation, while
microwave irradiation was carried out in Synthos-3000 Anton
Paar, microwave reaction system.
2.2. Chemical synthesis
The conventional method involves the reaction of 2-chloro-6-
methylquinoline-3-carbaldehyde (1) and 4-nitrophenyl hydrazidein the presence of a catalytic amount of glacial acetic acid
in ethanol to form aroylhydrazone (2), the same reaction
performed under the microwave irradiation, same starting
material in 1,4-dioxane (5 drops) was subjected to microwave
irradiation at 200 W intermittently at 30 s intervals for the
speciﬁed time to obtain aroylhydrazone (2) as a product. In
the third step, aroylhydrazone (2) was cyclized by reﬂuxing
with excessive amount of acetic anhydride for 6 h which re-
sulted in product (3), while in microwave irradiation Silica
gel (1 g) was added to the mixture of aroylhydrazone (2) and
acetic anhydride (2 mL) and was irradiated in microwave oven
at 400 W intermittently at 30 s intervals for 3–4 times to yield
(3). In the ﬁnal step, intermediate (3) was reacted with substi-
tuted aldehydes in the presence of KOH (0.01 mol) in 25 mL
ethanol (95%) for 6 h to furnish the ﬁnal product 1-[2-(2-
chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)(1,3,4-oxadiaz-
olin-3-yl)]-3-(aryl)prop-2-en-1-ones (4a–l), while the same
product is obtained by microwave irradiation at 100 W inter-
mittently at 30 s intervals for the speciﬁed time. Thus, the ﬁnal
product (4a–l) is obtained.
2.2.1. General procedure for the synthesis of N-[(1E)-1-aza-2-
(2-chloro-6-methyl(3-quinolyl))vinyl]-(4-nitrophenyl)
carboxamide (2)
2.2.1.1. Conventional method. A mixture of 2-chloro-6-methyl-
quinoline-3-carbaldehyde (1) and 4-nitrophenyl hydrazide was
mixed and dissolved in ethanol and a few drops of glacial ace-
tic acid was added and the mixture was reﬂuxed for 5–6 h by
using a reﬂux condenser. After cooling, the crystals formed
were ﬁltered off and recrystallized from alcohol (99.5%) to
give product (2). m.p. 128–130 C, yield 71%; IR (cm1):
3034 (aromatic–H), 1676 (C‚O), 1608 (C‚N), 1593, 1563,
1432 (C‚C benzene and quinoline ring), 1340 (–NO2 symmet-
ric stretching), 1522 (–NO2 asymmetric stretching), 761, 774
(C–Cl bond, mono substituted benzene). 1H NMR: d 2.43 (s,
3H, –CH3), 7.50 (s, 1H, N‚C–H), 7.51–8.90 (m, 8H, quino-
line–H and Ar–H), 10.88 (s, 1H, O‚C–N–H); 13C NMR: d
24.7, 124.0, 124.1, 126.4, 126.6, 127.0, 128.4, 132.5, 136.6,
137.2, 140.3, 142.9, 147.8, 151.3, 151.6, 162.9; MS: m/z
368.78 (M+). Anal. calcd. for C18H13ClN4O3: C, 58.62; H,
3.55; N, 15.19. Found: C, 58.67; H. 3.61; N, 15.26%.
2.2.1.2. Microwave method. A mixture of 2-chloro-6-methyl-
quinoline-3-carbaldehyde (0.01 mol), 4-nitrophenyl hydrazide
(0.01 mol) and 1,4-dioxane (5 drops) was subjected to microwave
Scheme 2 The mechanism of the synthesized compound 4a–l.
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speciﬁed time (Table 2). On completion of the reaction, it
was monitored by TLC, the reaction mixture was cooled and
treated with chilled water. The precipitate thus obtained was
ﬁltered, washed with water and recrystallized from ethanol
to afford 2.
The progress of the reaction and the purity of the com-
pound were routinely checked on TLC aluminium sheet silica
gel 60 F245 (E. Merck) using benzene–acetonitrile (4:1, v/v) as
an irrigator and was developed in iodine chamber.
2.2.2. General procedure for the synthesis 3-acetyl-2-(2-chloro-
6-methyl(3-quinolyl))-5-(4-nitrophenyl)-1,3,4-oxadiazoline (3)
2.2.2.1. Conventional method. Acetic anhydride (0.02 mol) was
added to the aroylhydrazone (2) (0.01 mol) and reﬂuxed for2 h. After cooling, the reaction mixture was poured into ice-cold
water. The precipitate was ﬁltered off, washed with water,
dried and recrystallized from DMF–ethanol to give the prod-
uct (3). m.p. 185–187 C, yield 67%; IR (cm1): 3034 (aro-
matic–H), 1675 (C‚O), 1607 (C‚N), 1590, 1563, 1431
(C‚C, benzene and quinoline ring), 1341 (–NO2 symmetric
stretching), 1523 (–NO2 asymmetric stretching), 1204 (C–O–
C linkage), 762, 774 (C–Cl bond, mono substituted benzene).
1H NMR: d 2.02 (s, 3H, –CO–CH3), 2.43 (s, 3H, –CH3),
6.61 (s, 1H, N–CH–quinoline ring), 7.47–8.34 (m, 8H, quino-
line–H and Ar–H); 13C NMR: d 23.4, 24.7, 69.8, 124.0,
125.8, 126.4, 126.5, 130.1, 130.7, 131.4, 135.6, 135.9, 136.4,
143.5, 150.2, 150.8, 155.0, 168.5; MS: m/z 410.81 (M+). Anal.
calcd. for C20H15ClN4O4: C, 58.47; H, 3.68; N, 13.63. Found:
C, 58.53; H, 3.74; N, 13.69%.
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mixture of aroylhydrazone (0.01 mol) and acetic anhydride
(2 mL) at room temperature. The reaction mixture was thor-
oughly mixed and the absorbed material was dried in air
and irradiated in a microwave oven at 400 W intermittently
at 30 s intervals for the speciﬁed time (Table 2). The reac-
tion mixture was cooled and the product was extracted in
methanol. Dilution of methanol solution with ice-cold water
gave the crude product, which was ﬁltered, washed with
water and recrystallized from methanol to give product (3).
The progress of the reaction and the purity of the com-
pound were routinely checked on TLC aluminium sheet silica
gel 60 F245 (E. Merck) using benzene–acetonitrile (4:1, v/v) as
an irrigator and was developed in iodine chamber.
2.2.3. General synthesis of 1-[2-(2-chloro-6-methyl(3-quinolyl))
-5-(4-nitrophenyl)(1,3,4-oxadiazolin-3-yl)]-3-(3-hydroxyphen
yl)prop-2-en-1-one (4h)
2.2.3.1. Conventional method. A mixture of (3) (0.01 mol)
and 3-hydroxybenzaldehyde (0.01 mol) was stirred in the
presence of KOH (0.01 mol) in 25 mL ethanol (95%) for
6 h. The yellow crystals formed were ﬁltered off, washed
with water and crystallized from ethanol (99.5%). m.p.
249–251 C, yield 74%. Anal. calcd. for C27H19ClN4O5: C,
62.98; H, 3.71; N, 10.88. Found: C, 62.95; H, 3.76; N,
10.92%.
2.2.3.2. Microwave method. A mixture of compound (3)
(0.01 mol), 3-hydroxybenzaldehyde (0.01 mol), potassium
hydroxide and ethanol (95%) (1 mL) was subjected to micro-
wave irradiation at 100 W intermittently at 30 s intervals for
the speciﬁed time (Table 2). On completion of the reaction
as monitored by TLC, the reaction mixture was cooled. The
precipitate thus obtained was ﬁltered and recrystallized from
ethanol (95%) to afford the ﬁnal compound (4h).
The progress of the reaction and the purity of the com-
pound were routinely checked on TLC aluminium sheet silica
gel 60 F245 (E. Merck) using benzene–acetonitrile (4:1, v/v) as
an irrigator and was developed in iodine chamber.
Other compounds of the series were prepared by using the
same conventional and microwave method and their physical
data are recorded (Tables 1 and 2).
2.3. Spectral characterization and elemental analysis of
compounds 4a–l
2.3.1. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(2-chlorophenyl)prop-2-en-1-one
(4a)
IR (KBr) (cm1): 3038 (aromatic–H), 3058 (CH‚CH group),
2911 (C–H stretching), 1672 (C‚O), 1609 (C‚N), 1595, 1561,
1433 (C‚C, benzene and quinoline ring), 1342 (–NO2 sym-
metric stretching), 1543 (–NO2 asymmetric stretching), 1218
(C–O–C linkage), 760, 771 (C–Cl bond, mono substituted ben-
zene). 1H NMR (DMSO-d6): d 2.43 (s, 3H, –CH3 group), 6.61
(s, 1H, N–CH–quinoline ring), 6.67 (d, 1H, O‚C–C–H), 7.82
(d, 1H, ‚C–H), 7.06–8.34 (m, 12H, quinoline–H and Ar–H);
13C NMR: d 24.7, 70.1, 118.8, 124.0, 125.8, 126.4, 126.5,
126.8, 127.8, 128.7, 129.4, 130.1, 130.7, 131.1, 131.4, 133.0,
135.6, 135.9, 136.4, 143.5, 150.0, 150.8, 155.0, 167.0; MS: m/
z 533.37 (M+). Anal. calcd. for C27H18Cl2N4O4: C, 60.80; H,
3.40; N, 10.50. Found: C, 60.85; H, 3.47; N, 10.55%.2.3.2. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(3-chlorophenyl)prop-2-en-1-one
(4b)
IR (KBr) (cm1): 3052 (aromatic–H), 3063 (CH‚CH group),
2911 (C–H stretching), 1682 (C‚O), 1614 (C‚N), 1583, 1541,
1433 (C‚C, benzene and quinoline ring), 1458 (C–H bending),
1346 (–NO2 symmetric stretching), 1522 (–NO2 asymmetric
stretching), 1209 (C–O–C linkage), 761, 775 (C–Cl bond, mono
substituted benzene). 1H NMR (DMSO-d6): d 2.43 (s, 3H, –
CH3 group), 6.84 (d, 1H, O‚C–C–H), 7.55 (d, 1H, ‚C–H),
6.61 (s, 1H, N–CH–quinoline ring), 7.15–8.34 (m, 12H, quino-
line–H and Ar–H); 13C NMR: d 24.5, 70.1, 118.8, 124.0, 125.8,
126.4, 126.5, 127.8, 128.7, 130.1, 130.7, 131.4, 133.3, 133.5,
135.6, 135.9, 136.4, 143.5, 144.0, 150.2, 150.8, 155.1, 167.2;
MS: m/z 533.37 (M+). Anal. calcd. for C27H18Cl2N4O4: C,
60.80; H, 3.40; N, 10.50. Found: C, 60.84; H, 3.46; N, 10.56%.
2.3.3. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(4-chlorophenyl)prop-2-en-1-one
(4c)
IR (KBr) (cm1): 3039 (aromatic–H), 3064 (CH‚CH group),
2910 (C–H stretching), 1684 (C‚O), 1609 (C‚N), 1607, 1571,
1443 (C‚C, benzene and quinoline ring), 1451 (C–H bending),
1343 (–NO2 symmetric stretching), 1521 (–NO2 asymmetric
stretching), 1205 (C–O–C linkage), 757, 778 (C–Cl bond, mono
substituted benzene). 1HNMR (DMSO-d6): d 2.43 (s, 3H, –CH3
group), 6.61 (s, 1H, N–CH–quinoline ring), 6.84 (d, 1H, O‚C–
C–H), 7.55 (d, 1H, ‚C–H), 7.15–8.34 (m, 12H, quinoline–H
and Ar–H); 13C NMR: d 24.6, 70.1, 118.7, 124.0, 125.8, 126.4,
126.5, 127.8, 128.7, 130.7, 130.1, 131.4, 133.3, 133.5, 135.6,
135.9, 136.4, 143.5, 144.0, 150.2, 150.8, 155.0, 167.3; MS: m/z
533.37 (M+). Anal. calcd. for C27H18Cl2N4O4: C, 60.80; H,
3.40; N, 10.50. Found: C, 60.86; H, 3.46; N, 10.55%.
2.3.4. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(2-nitrophenyl)prop-2-en-1-one
(4d)
IR (KBr) (cm1): 3063 (aromatic–H), 3058 (CH‚CH group),
2917 (C–H stretching), 1687 (C‚O), 1590 (C‚N), 1585, 1545,
1427 (C‚C, benzene and quinoline ring), 1461 (C–H bending),
1219 (C–O–C linkage), 1349 (–NO2 symmetric stretching), 1516
(–NO2 asymmetric stretching), 758, 775 (C–Cl bond, mono
substituted benzene). 1H NMR (DMSO-d6): d 2.43 (s, 3H, –
CH3 group), 6.61 (s, 1H, N–CH–quinoline ring), 6.91 (d, 1H,
O‚C–C–H), 7.56–8.34 (m, 12H, quinoline–H and Ar–H),
8.11 (d, 1H, ‚C–H); 13C NMR: d 24.5, 70.3, 118.8, 123.8,
124.0, 125.8, 126.4, 126.5, 127.2, 127.3, 128.9, 130.1, 130.7,
131.4, 134.8, 135.6, 135.9, 136.4, 143.5, 144.0, 145.0, 150.2,
150.8, 155.0, 167.2; MS: m/z 543.92 (M+). Anal. calcd. for
C27H18ClN5O6: C, 59.62; H, 3.33; N, 12.87. Found: C, 59.67;
H, 3.39; N, 12.93%.
2.3.5. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(3-nitrophenyl)prop-2-en-1-one
(4e)
IR (KBr) (cm1): 3057 (aromatic–H), 3081 (CH‚CH
group), 2918 (C–H stretching), 1678 (C‚O), 1608 (C‚N),
1589, 1558, 1430 (C‚C, benzene and quinoline ring), 1219
(C–O–C linkage), 1353 (–NO2 symmetric stretching), 1462
(C–H bending), 1524 (–NO2 asymmetric stretching), 763,
774 (C–Cl bond, mono substituted benzene). 1H NMR
(DMSO-d6): d 2.43 (s, 3H, –CH3 group), 6.61 (s, 1H,
S384 N.C. Desai, A.M. DodiyaN–CH–quinoline ring), 7.57–8.34 (m, 12H, quinoline–H and
Ar–H), 7.09 (d, 1H, O‚C–C–H), 7.66 (d, 1H, ‚C–H); 13C
NMR: d 24.7, 70.1, 118.8, 120.0, 123.1, 124.0, 125.8, 126.4,
126.5, 129.6, 130.1, 130.7, 131.4, 132.5, 135.6, 135.9, 136.1,
136.4, 143.5, 144.0, 147.8, 150.2, 150.8, 155.0, 167.0; MS:
m/z 543.92 (M+). Anal. calcd. for C27H18ClN5O6: C,
59.62; H, 3.33; N, 12.87. Found: C, 59.68; H, 3.37; N,
12.93%.
2.3.6. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(4-nitrophenyl)prop-2-en-1-one
(4f)
IR (KBr) (cm1): 3039 (aromatic–H), 3065 (CH‚CH
group), 2921 (C–H stretching), 1672 (C‚O), 1616 (C‚N),
1597, 1561, 1434 (C‚C, benzene and quinoline ring), 1460
(C–H bending), 1216 (C–O–C linkage), 1342 (–NO2 symmet-
ric stretching), 1523 (–NO2 asymmetric stretching), 756, 768
(C–Cl bond, mono substituted benzene). 1H NMR (DMSO-
d6): d 2.43 (s, 3H, –CH3 group), 6.61 (s, 1H, N–CH–quino-
line ring), 7.13 (d, 1H, O‚C–C–H), 7.69 (d, 1H, ‚C–H),
7.57–8.34 (m, 12H, quinoline–H and Ar–H); 13C NMR: d
24.6, 70.2, 118.8, 123.8, 124.0, 125.8, 126.4, 126.5, 127.3,
130.1, 130.7, 131.4, 135.6, 135.9, 136.4, 141.3, 143.5, 144.0,
147.1, 150.2, 150.7, 155.1, 167.2; MS: m/z 543.92 (M+).
Anal. calcd. for C27H18ClN5O6: C, 59.62; H, 3.33; N,
12.87. Found: C, 59.67; H, 3.38; N, 12.94%.
2.3.7. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(2-hydroxyphenyl)prop-2-en-1-one
(4g)
IR (KBr) (cm1): 3060 (aromatic–H), 3420 (aromatic–OH
group), 3087 (CH‚CH group), 2906 (C–H stretching),
1681 (C‚O), 1612 (C‚N), 1608, 1565, 1405 (C‚C, ben-
zene and quinoline ring), 1212 (C–O–C linkage), 1353
(–NO2 symmetric stretching), 1468 (C–H bending), 1523
(–NO2 asymmetric stretching), 756, 768 (C–Cl bond, mono
substituted benzene). 1H NMR (DMSO-d6): d 2.43 (s, 3H,
–CH3 group), 6.61 (s, 1H, N–CH–quinoline ring), 6.67 (d,
1H, O‚C–C–H), 6.68–8.34 (m, 12H, quinoline–H and Ar–
H), 7.82 (d, 1H, ‚C–H), 9.82 (s, 1H, aromatic–OH group);
13C NMR: d 24.7, 70.1, 115.5, 116.5, 118.8, 121.3, 124.0,
125.8, 126.4, 126.5, 127.8, 129.4, 130.1, 130.7, 131.4, 135.6,
135.9, 136.4, 143.5, 144.0, 150.2, 150.8, 155.0, 158.3, 167.0;
MS: m/z 514.92 (M+). Anal. calcd. for C27H19ClN4O5: C,
62.98; H, 3.71; N, 10.88. Found: C, 62.99; H, 3.77; N,
10.93%.
2.3.8. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(3-hydroxyphenyl)prop-2-en-1-one
(4h)
IR (KBr) (cm1): 3048 (aromatic–H), 3429 (aromatic–OH
group), 3093 (CH‚CH group), 2915 (C–H stretching),
1675 (C‚O), 1611 (C‚N), 1593, 1561, 1425 (C‚C, ben-
zene and quinoline ring), 1354 (–NO2 symmetric stretching),
1458 (C–H bending), 1533 (–NO2 asymmetric stretching),
1207 (C–O–C linkage), 758, 764 (C–Cl bond, mono substi-
tuted benzene). 1H NMR (DMSO-d6): d 2.43 (s, 3H, –CH3
group), 6.61 (s, 1H, N–CH–quinoline ring), 6.84 (d, 1H,
O‚C–C–H), 7.55 (d, 1H, ‚C–H), 7.57–8.34 (m, 12H, quin-
oline–H and Ar–H), 9.82 (s, 1H, aromatic–OH group); 13C
NMR: d 24.5, 70.3, 112.1, 115.1, 188.8, 119.0, 124.0,
125.8, 126.4, 126.5, 130.1, 130.7, 131.4, 135.6, 135.9, 136.4,136.6, 143.5, 144.0, 150.2, 150.8, 155.0, 158.4, 167.2; MS:
m/z 514.92 (M+). Anal. calcd. for C27H19ClN4O5: C,
62.98; H, 3.71; N, 10.88. Found: C, 62.96; H, 3.76; N,
10.92%.
2.3.9. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl)
(1,3,4-oxadiazolin-3-yl)]-3-(4-hydroxyphenyl)prop-2-en-1-one
(4i)
IR (KBr) (cm1): 3064 (aromatic–H), 3429 (aromatic–OH
group), 3075 (CH‚CH group), 2911 (C–H stretching), 1673
(C‚O), 1602 (C‚N), 1608, 1564, 1423 (C‚C, benzene and
quinoline ring), 1460 (C–H bending), 1341 (–NO2 symmetric
stretching), 1522 (–NO2 asymmetric stretching), 1219 (C–O–
C linkage), 761, 769 (C–Cl bond, mono substituted benzene).
1H NMR (DMSO-d6): d 2.43 (s, 3H, –CH3 group), 6.61 (s,
1H, N–CH–quinoline ring), 6.67 (d, 1H, O‚C–C–H), 7.57–
8.83 (m, 12H, quinoline–H and Ar–H), 7.82 (d, 1H, ‚C–H),
9.82 (s, 1H, aromatic–OH group); 13C NMR: d 24.5, 70.1,
115.8, 118.8, 124.0, 125.8, 126.4, 126.5, 127.8, 130.1, 130.7,
131.4, 135.6, 135.9, 136.4, 143.5, 144.0, 150.2, 150.8, 155.0,
157.7, 167.0; MS: m/z 514.92 (M+). Anal. calcd. for
C27H19ClN4O5: C, 62.98; H, 3.71; N, 10.88. Found: C, 62.97;
H, 3.77; N, 10.94%.
2.3.10. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl )
(1,3,4-oxadiazolin-3-yl)]-3-(4-methylphenyl)prop-2-en-1-one
(4j)
IR (KBr) (cm1): 3032 (aromatic–H), 3072 (CH‚CH
group), 2892, 2911 (C–H stretching), 1681 (C‚O), 1605
(C‚N), 1579, 1554, 1432 (C‚C, benzene and quinoline
ring), 1440, 1461 (C–H bending), 1345 (–NO2 symmetric
stretching), 1535 (–NO2 asymmetric stretching), 1209
(C–O–C linkage), 761, 775 (C–Cl bond, mono substituted
benzene). 1H NMR (DMSO-d6): d 2.43 (s, 3H, –CH3 group),
2.40 (s, 3H, –CH3 group), 6.61 (s, 1H, N–CH–quinoline
ring), 6.84 (d, 1H, O‚C–C–H), 7.55 (d, 1H, ‚C–H),
7.57–8.34 (m, 12H, quinoline–H and Ar–H); 13C NMR: d
24.3, 24.7, 70.1, 118.8, 124.0, 125.8, 126.3, 126.4, 126.5,
128.9, 130.1, 130.7, 131.4, 132.2, 135.6, 135.9, 136.4, 137.6,
143.5, 144.0, 150.2, 150.8, 155.0, 167.3; MS: m/z 512.95
(M+). Anal. calcd. for C28H21ClN4O4: C, 65.56; H, 4.12;
N, 10.92. Found: C, 65.62; H, 4.18; N, 10.97%.
2.3.11. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl )
(1,3,4-oxadiazolin-3-yl)]-3-(4-methoxyphenyl)prop-2-en-1-one
(4k)
IR (KBr) (cm1): 3041 (aromatic–H), 3068 (CH‚CH
group), 2920 (C–H stretching), 2833 (Ar–OCH3), 1673
(C‚O), 1609 (C‚N), 1611, 1562, 1436 (C‚C, benzene
and quinoline ring), 1342 (–NO2 symmetric stretching),
1520 (–NO2 asymmetric stretching), 1277 (Ar–O–Me), 1462
(C–H bending), 1209 (C–O–C linkage), 758, 780 (C–Cl
bond, mono substituted benzene). 1H NMR (DMSO-d6): d
2.43 (s, 3H, –CH3 group), 3.85 (s, 3H, –OCH3 group),
6.61 (s, 1H, N–CH–quinoline ring), 6.68–8.34 (m, 12H, quin-
oline–H and Ar–H), 6.84 (d, 1H, O‚C–C–H), 7.55 (d, 1H,
‚C–H); 13C NMR: d 24.4, 55.8, 70.1, 114.2, 118.8, 124.0,
125.8, 126.4, 126.5, 127.4, 127.5, 130.1, 130.7, 131.4, 135.6,
135.9, 136.4, 143.5, 144.0, 150.2, 150.8, 155.0, 159.8, 167.2;
MS: m/z 528.95 (M+). Anal. calcd. for C28H21ClN4O5: C,
63.58; H, 4.00; N, 10.59. Found: C, 63.64; H, 4.06; N,
10.65%.
Conventional and microwave techniques for the synthesis and antimicrobial studies of novel S3852.3.12. 1-[2-(2-Chloro-6-methyl(3-quinolyl))-5-(4-nitrophenyl
)(1,3,4-oxadiazolin-3-yl)]-3-(3,4,5–trimethoxyphenyl)prop-2-
en-1-one (4l)
IR (KBr) (cm1): 3070 (aromatic–H), 3064 (CH‚CH
group), 2914 (C–H stretching), 2841 (Ar–OCH3), 1671
(C‚O), 1610 (C‚N), 1608, 1570, 1442 (C‚C, benzene
and quinoline ring), 1343 (–NO2 symmetric stretching),
1522 (–NO2 asymmetric stretching), 1284 (Ar–O–Me), 1359
(–NO2 symmetric stretching), 1466 (C–H bending), 1525
(–NO2 asymmetric stretching), 1209 (C–O–C linkage), 756,
774 (C–Cl bond, mono substituted benzene). 1H NMR
(DMSO-d6): d 2.43 (s, 3H, –CH3 group), 3.71–3.83 (s, 9H,
–OCH3 group), 6.61 (s, 1H, N–CH–quinoline ring), 6.84
(d, 1H, O‚C–C–H), 6.78–8.34 (m, 9H, quinoline–H and
Ar–H), 7.55 (d, 1H, ‚C–H); 13C NMR: d 24.5, 70.3,
56.1, 103.8, 118.8, 124.0, 125.8, 126.4, 126.5, 129.5, 130.1,
130.7, 131.4, 135.6, 135.9, 136.4, 143.5, 144.0, 150.2, 150.7,
150.8, 155.1, 167.1; MS: m/z 589.00 (M+). Anal. calcd. for
C30H25ClN4O7: C, 61.17; H, 4.27; N, 9.51. Found: C,
61.22; H, 4.32; N, 9.56%.Figure 1 Carbon numbering of the compound 4h.3. Results and discussion
All the reactions (steps 2–4) were completed in 6–8 h by the
conventional method, while under MWI, the same reactions
were completed in 3–5 min, and also observed in good yield
as compared to the conventional method. A comparative study
in terms of yield and reaction period is shown in Tables 1 and 2.
3.1. IR-data
The IR spectrum of the title compound 4h (molecular formula
C27H19ClN4O5, M.W. 514.92) has given vibration at
3048 cm1 over the range which shows multiple weak absorp-
tion peaks corresponding to Qu–H and Ar–H stretching vibra-
tion absorption peaks. The absorption at 2915 cm1 is due to
the aromatic –CH3 group stretching vibration, while the
absorption at 1458 cm1 is due to the aromatic–CH3 group
bending vibration. The strong absorption at 1675 cm1 is
due to the C‚O stretching vibration and the moderate inten-
sity absorption at 1611 cm1 corresponds to a C‚N stretching
vibration and C‚C linkage appeared stretching vibration at
1595 cm1. The absorption at 1354 cm1 is due to the symmet-
ric stretching of –NO2 group while the absorption at
1533 cm1 is due to the asymmetric stretching of –NO2 group.
The high frequency region of the IR spectra of these compounds
contains –OH stretching vibration bands at 3429 cm1. While
in oxadiazole nucleus C–O–C linkage appeared in the range of
1207 cm1. Methylene (CH‚CH) linkage appeared in the
stretching vibration range of 3093 cm1, while methylene
linkage appeared in the bending vibration range of 825 cm1,
the absorption peak at 758 cm1 arises due to the C–Cl group
and the absorption peak at 764 cm1 indicates that a mono
substituted benzene ring is present.
3.2. 1H NMR-data
It can be seen from the chemical structure of compound 4h
that different pairs of carbons, e.g., C-14 and C-18, C-15
and C-17 are attached to the chemically equivalent protons,
which appeared at d = 8.09 and 8.34 ppm, respectively. Theprotons attached to C-10 position appeared as a singlet at
d = 2.43 ppm due to the –CH3 group. The proton attached
to the C-7 position appeared as a doublet at 7.47 ppm, while
the proton attached to the C-8 position also appeared as a
doublet at d = 7.83 ppm. Chemical shift in the aromatic re-
gion with a multiplet centered at d = 8.05 ppm corresponds
to C-3, while the C-11 (–CH group) present in the oxadiazole
nucleus appeared at d = 6.61 ppm. The protons, which are
present in the alkene linkage, C-20 and C-21 give doublet,
C-20 appeared at d = 6.84 ppm, because of the vicinity of car-
bonyl group at C-19, while the proton of C-21 appeared at
d = 7.55 ppm, because it is directly attached to the phenyl
ring. The proton of the –OH group appeared at
d = 9.83 ppm, –OH functional group is attached to C-24,
while four other protons attached to carbons C-23, C-25,
C-26, and C-27 in the phenyl ring appeared as a multiplet at
d = 6.61–7.04 ppm.
3.3. 13C NMR-data
The ﬁnal compound 4h contains three moieties, such as quin-
oline, oxadiazole and chalcone. The chemical shifts of the car-
bons of the ﬁnal compound 4h carbons vary from d = 167.0 to
70.1 ppm. The carbon nuclei under the inﬂuence of a strong
electronegative environment appeared downﬁeld, e.g., the
C-19 carbonyl, which is directly linked to the ring nitrogen that
has a chemical shift at d = 167.0 ppm, whereas the C-1 linked
to one chlorine and other nitrogen atom, appeared at
d = 150.8 ppm. The chemical shift of the ring carbon at C-9
is affected by the presence of a directly attached ring nitrogen
atom and appeared at d = 143.5 ppm. While the alkene car-
bon at C-20 is directly attached to a carbonyl group and then
appeared at d = 118.8 ppm. The alkene carbon at C-21 di-
rectly conjugated to the phenyl ring, indicates a downﬁeld
chemical shift at d = 144.0 ppm. The carbons of the phenyl
ring (C-22, C-23, C-25, C-26 and C-27) conjugated to the al-
kene functionality have chemical shifts in the range
d = 115.1–136.6 ppm. While the C-24, which is attached to a
hydroxyl group appeared at d = 158.4 ppm, under the strong
electron withdrawing inﬂuence exerted by the hydroxyl group.
The carbon of the methyl group C-10 appeared at
d = 24.7 ppm. While, the carbons which are present in the
oxadiazole nucleus C-11 and C-12 are directly attached to oxy-
gen atom on one side and on the other side C-11 is attached to
the nitrogen with a single bond. So, it gives a chemical shift at
d = 70.1 ppm, while on the other side C-12 is attached to the
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S386 N.C. Desai, A.M. Dodiyanitrogen atom by a double bond, so, it gives a chemical shift at
d = 155.0 ppm. The carbons of the quinoline ring (C-2, C-3,
C-4, C-5, C-6, C-7 and C-8) appeared upﬁeld between
d = 125.8 and 136.4 ppm compared to those quinoline ring
carbons at C-1 and C-9. The carbon C-13 which is present in
the phenyl ring and which is attached to the oxadiazole nucleus
carbon C-12, appeared at 135.9 ppm. The equivalent carbons
C-14 and C-18 appeared at d = 130.1 ppm, while other equiv-
alent carbons C-15 and C-17 appeared at 124.0 ppm. While
C-16 which is directly attached to the nitro group appeared
at 150.2 ppm, respectively. Carbon numbering is described in
Fig. 1.
3.4. Antimicrobial activity
Minimum inhibitory concentration for bacteria (MICb) of all
the synthesized compounds was determined against four differ-
ent strains, viz. two gram positive bacteria (Staphylococcus
aureus and Staphylococcus pyogenes and two gram negative
bacteria (Escherichia coli and Pseudomonas aeruginosa) com-
pared to the standard drug ampicillin by broth dilution meth-
od (Rattan, 2000). For antifungal activities, minimum
inhibitory concentration for fungi (MICf) of all the synthesized
compounds was determined againstCandida albicans,Aspergil-
lus niger and Aspergillus clavatus organisms. The results were
compared with standard drug griseofulvin by the same meth-
od, which showed 100 lg/mL MICf against all fungi used for
antifungal activity. We have synthesized 1-[2-(2-chloro-6-
methyl(3-quinolyl))-5-(4-nitrophenyl)(1,3,4-oxadiazolin-3-yl)]-
3-(aryl)prop-2-en-1-ones (4a–l) derivatives (Table 3).
3.4.1. Antibacterial activity
From screening results, it has been observed that ﬁnal com-
pounds 4c, 4f and 4k possess good activity against E. coli
while compound 4d has better activity against E. coli and
compound 4h has excellent activity against E. coli as com-
pared to standard drug ampicillin. Final compounds 4c
and 4j possess good activity against P. aeruginosa and com-
pounds 4d and 4h possess very good activity against P. aeru-
ginosa as compared to the standard drug ampicillin. Final
compounds 4b, 4f, 4g, 4i and 4k possess very good activity
against S. aureus, while compounds 4c and 4j possess excel-
lent activity against S. aureus as compared to standard drug
ampicillin. Final compounds 4b, 4e, 4h and 4k were consid-
ered as good active against S. pyogenes and compound 4f
possesses very good activity as compared to the standard
drug ampicillin. The remaining compounds of the series pos-
sess moderate to poor antibacterial activity.T
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13.4.2. Antifungal activity
Antifungal screening data showed that ﬁnal compounds 4c, 4d,
4f, 4h, 4i and 4k possess good activity against C. albicans, while
compound 4j possesses very good activity against C. albicans
and compounds 4b, 4e and 4l possess excellent activity as
compared to the standard drug griseofulvin. Compounds 4b,
4e, 4i, 4j and 4l possess good activity against A. niger as com-
pared to the standard drug griseofulvin. Compounds 4d, 4f, 4h,
4k and 4l possess good activity against A. clavatus as compared
to the standard drug griseofulvin. The remaining compounds
of the entire series possess only moderate to poor antifungal
activity.
Conventional and microwave techniques for the synthesis and antimicrobial studies of novel S3873.4.3. Statistical analysis
The standard deviation value is expressed in terms of ±SD.
On the basis of the calculated value by using ANOVA method,
it has been observed that the differences below 0.0001 level
(p 6 0.0001) were considered as statistically signiﬁcant.4. Conclusion
We have synthesized a variety of quinoline–oxadiazole con-
taining chalcone derivatives under classical and microwave
conditions. In general, improvements in the rate and yield
of reactions were observed in MWI. When organic reactions
were carried out under microwave as compared to classical
conditions, it may be observed that activation occurs at dif-
ferent temperatures with these techniques and, therefore,
strict comparisons will require a balance between effective-
ness and energy costs. In general, compounds with electron
withdrawing groups showed good antibacterial and anti-
fungal activities. These results proved that novel quinoline,
oxadiazole and chalcone based heterocyclic compounds are
found to be interesting lead molecules for further synthetic
and biological evaluation.Acknowledgements
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